Eagle Asset Management Inc. boosted its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 99.6% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 30,877 shares of the company’s stock after buying an additional 15,408 shares during the period. Eagle Asset Management Inc.’s holdings in Henry Schein were worth $2,501,000 at the end of the most recent reporting period.
Other large investors have also modified their holdings of the company. Great West Life Assurance Co. Can raised its holdings in shares of Henry Schein by 102.4% in the 3rd quarter. Great West Life Assurance Co. Can now owns 859,577 shares of the company’s stock worth $69,482,000 after purchasing an additional 434,833 shares during the period. Washington Capital Management Inc. raised its holdings in shares of Henry Schein by 97.6% in the 3rd quarter. Washington Capital Management Inc. now owns 5,650 shares of the company’s stock worth $463,000 after purchasing an additional 2,790 shares during the period. Nordea Investment Management AB raised its holdings in shares of Henry Schein by 606.5% in the 3rd quarter. Nordea Investment Management AB now owns 24,933 shares of the company’s stock worth $2,044,000 after purchasing an additional 21,404 shares during the period. Peloton Wealth Strategists raised its holdings in shares of Henry Schein by 127.3% in the 3rd quarter. Peloton Wealth Strategists now owns 23,750 shares of the company’s stock worth $1,947,000 after purchasing an additional 13,300 shares during the period. Finally, TD Asset Management Inc. raised its holdings in shares of Henry Schein by 99.8% in the 3rd quarter. TD Asset Management Inc. now owns 302,006 shares of the company’s stock worth $24,761,000 after purchasing an additional 150,837 shares during the period. 91.75% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities analysts have recently commented on HSIC shares. Zacks Investment Research downgraded Henry Schein from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Credit Suisse Group reiterated a “hold” rating and set a $87.50 target price on shares of Henry Schein in a report on Tuesday, August 29th. Piper Jaffray Companies upgraded Henry Schein from a “neutral” rating to an “overweight” rating in a report on Friday, September 15th. UBS reiterated a “buy” rating on shares of Henry Schein in a report on Friday, September 15th. Finally, Royal Bank Of Canada began coverage on Henry Schein in a report on Tuesday, September 19th. They set a “sector perform” rating and a $91.00 target price on the stock. Two analysts have rated the stock with a sell rating, nine have assigned a hold rating and seven have given a buy rating to the company. Henry Schein has an average rating of “Hold” and an average price target of $88.36.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Monday, November 6th. The company reported $0.87 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.90 by ($0.03). The business had revenue of $3.16 billion for the quarter, compared to analysts’ expectations of $3.05 billion. Henry Schein had a return on equity of 19.71% and a net margin of 4.52%. Henry Schein’s revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.84 earnings per share. equities analysts anticipate that Henry Schein, Inc. will post 3.6 earnings per share for the current fiscal year.
Henry Schein declared that its Board of Directors has approved a stock repurchase program on Monday, September 18th that permits the company to repurchase $400.00 million in shares. This repurchase authorization permits the company to buy up to 6.3% of its stock through open market purchases. Stock repurchase programs are often an indication that the company’s management believes its shares are undervalued.
In other news, Director Barry J. Alperin sold 5,796 shares of Henry Schein stock in a transaction that occurred on Friday, December 1st. The stock was sold at an average price of $70.76, for a total value of $410,124.96. Following the completion of the transaction, the director now owns 48,172 shares in the company, valued at approximately $3,408,650.72. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. 1.19% of the stock is currently owned by company insiders.
Henry Schein Profile
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Receive News & Ratings for Henry Schein Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein Inc. and related companies with MarketBeat.com's FREE daily email newsletter.